View in EDS HTML Full Text PDF Full Text

Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy.

Saved in:
Bibliographic Details
Title: Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy.
Authors: Sharma JB; Department of Clinical Pharmacology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India., Krishnamurthy MN; Department of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Sector 22, Kharghar, Maharashtra, Navi Mumbai 410210, India; Homi Bhabha National Institute, Mumbai, India., Awase A; Department of Clinical Pharmacology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India., Joshi A; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Dr. E. Borge's Road, Parel, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Patil V; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Dr. E. Borge's Road, Parel, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Noronha V; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Dr. E. Borge's Road, Parel, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Prabhash K; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Dr. E. Borge's Road, Parel, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Gota V; Department of Clinical Pharmacology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India Homi Bhabha National Institute, Mumbai, India.
Source: Therapeutic advances in drug safety [Ther Adv Drug Saf] 2021 Feb 11; Vol. 12, pp. 2042098621991280. Date of Electronic Publication: 2021 Feb 11 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 101549074 Publication Model: eCollection Cited Medium: Print ISSN: 2042-0986 (Print) Linking ISSN: 20420986 NLM ISO Abbreviation: Ther Adv Drug Saf Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33628419
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sharma+JB%22">Sharma JB</searchLink>; Department of Clinical Pharmacology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Krishnamurthy+MN%22">Krishnamurthy MN</searchLink>; Department of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Sector 22, Kharghar, Maharashtra, Navi Mumbai 410210, India; Homi Bhabha National Institute, Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Awase+A%22">Awase A</searchLink>; Department of Clinical Pharmacology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Joshi+A%22">Joshi A</searchLink>; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Dr. E. Borge's Road, Parel, Mumbai, India; Homi Bhabha National Institute, Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Patil+V%22">Patil V</searchLink>; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Dr. E. Borge's Road, Parel, Mumbai, India; Homi Bhabha National Institute, Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Noronha+V%22">Noronha V</searchLink>; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Dr. E. Borge's Road, Parel, Mumbai, India; Homi Bhabha National Institute, Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Prabhash+K%22">Prabhash K</searchLink>; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Dr. E. Borge's Road, Parel, Mumbai, India; Homi Bhabha National Institute, Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Gota+V%22">Gota V</searchLink>; Department of Clinical Pharmacology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India Homi Bhabha National Institute, Mumbai, India.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101549074%22">Therapeutic advances in drug safety</searchLink> [Ther Adv Drug Saf] 2021 Feb 11; Vol. 12, pp. 2042098621991280. <i>Date of Electronic Publication: </i>2021 Feb 11 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101549074 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2042-0986 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220420986%22">20420986 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Drug Saf <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33628419
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/2042098621991280
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2042098621991280
    Titles:
      – TitleFull: Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sharma JB
      – PersonEntity:
          Name:
            NameFull: Krishnamurthy MN
      – PersonEntity:
          Name:
            NameFull: Awase A
      – PersonEntity:
          Name:
            NameFull: Joshi A
      – PersonEntity:
          Name:
            NameFull: Patil V
      – PersonEntity:
          Name:
            NameFull: Noronha V
      – PersonEntity:
          Name:
            NameFull: Prabhash K
      – PersonEntity:
          Name:
            NameFull: Gota V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 02
              Text: 2021 Feb 11
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 2042-0986
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Therapeutic advances in drug safety
              Type: main
ResultId 1